| Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases JP Cannon, TA Lee, JT Bolanos, LH Danziger European Journal of Clinical Microbiology and Infectious Diseases 24, 31-40, 2005 | 613 | 2005 |
| The risk of seizures among the carbapenems: a meta-analysis JP Cannon, TA Lee, NM Clark, P Setlak, SA Grim Journal of Antimicrobial Chemotherapy 69 (8), 2043-2055, 2014 | 139 | 2014 |
| Management of pressure ulcers BC Cannon, JP Cannon American journal of health-system pharmacy 61 (18), 1895-1905, 2004 | 100 | 2004 |
| Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model JP Cannon, R Fiscella, S Pattharachayakul, KW Garey, F De Alba, ... Investigative ophthalmology & visual science 44 (5), 2112-2117, 2003 | 100 | 2003 |
| A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid‐based amphotericin B formulations JP Cannon, KW Garey, LH Danziger Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21 (9 …, 2001 | 75 | 2001 |
| The effectiveness and safety of oral linezolid for the primary and secondary treatment of osteomyelitis CO Aneziokoro, JP Cannon, CT Pachucki, JR Lentino Journal of chemotherapy 17 (6), 643-650, 2005 | 55 | 2005 |
| Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections KA Culos, JP Cannon, SA Grim American journal of therapeutics 20 (2), 200-212, 2013 | 46 | 2013 |
| Controlling antimicrobial use and decreasing microbiological laboratory tests for urinary tract infections in spinal-cord-injury patients with chronic indwelling catheters PS Shah, JP Cannon, CL Sullivan, B Nemchausky, CT Pachucki American journal of health-system pharmacy 62 (1), 74-77, 2005 | 42 | 2005 |
| Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital U Changela, JP Cannon, C Aneziokoro, PS Shah, L Thottapurathu, ... International journal of antimicrobial agents 24 (6), 562-566, 2004 | 40 | 2004 |
| Evaluation of antifungals in the surgical intensive care unit: a multi‐institutional study KW Garey, MM Neuhauser, DT Bearden, JP Cannon, RE Lewis, ... Mycoses 49 (3), 226-231, 2006 | 38 | 2006 |
| Pericardial infection caused by Brevibacterium casei JP Cannon, SL Spadoni, S Pesh-Iman, S Johnson Clinical Microbiology and Infection 11 (2), 164-165, 2005 | 22 | 2005 |
| Six‐month use of droxidopa for neurogenic orthostatic hypotension C François, CA Shibao, I Biaggioni, AM Duhig, K McLeod, A Ogbonnaya, ... Movement Disorders Clinical Practice 6 (3), 235-242, 2019 | 18 | 2019 |
| A pharmacist-driven antimicrobial approval program at a Veterans Affairs hospital. JP Cannon, RM Silverman American journal of health-system pharmacy 60 (13), 2003 | 16 | 2003 |
| Infections DJ Leehey, JP Cannon, JR Lentino ed.: Lippincott Williams & Wilkins, 2007 | 7 | 2007 |
| Amikacin Dosing and Monitoring in Spinal Cord Injury Patients: Variation in Clinical Practice Between Spinal Injury Units and Differences in Experts′ Recommendations S Vaidyanathan, C Peloquin, JJ Wyndaele, AZ Buczynski, Y Almog, ... The Scientific World Journal 6 (1), 187-199, 2006 | 7 | 2006 |
| cont rolling antimicrobial use and decreasing microbiological labortory tests for uri nary tract infections in Spinal ord-jury patients with chronic indwelling cat heters PS Shan, JP Cannon, CL Sullivan Am J Health Syst Pharm 62 (1), 74-77, 2005 | 5 | 2005 |
| The effectiveness and safety of oral linezolid as primary or secondary treatment of bloodstream infections: a retrospective observational analysis JP Cannon, CT Pachucki, CO Aneziokoro, JR Lentino Infectious Diseases in Clinical Practice 14 (4), 221-226, 2006 | 4 | 2006 |
| Patient-reported outcomes in a prospective real-world study of droxidopa for the treatment of neurogenic orthostatic hypotension S Kymes, C François, K McLeod, A Duhig, A Ogbonnaya, A Quillen, ... MOVEMENT DISORDERS 32, 2017 | 1 | 2017 |
| Prospective Study of Real-World Outcomes in the Treatment of Neurogenic Orthostatic Hypotension With Droxidopa (P5. 319) S Kymes, C François, K McLeod, A Duhig, A Ogbonnaya, A Quillen, ... Neurology 88 (16_supplement), P5. 319, 2017 | 1 | 2017 |
| Effects of dexamethasone administration and Revalor-S-(R) on growth, carcass characteristics and visceral organ and fat mass of finishing beef steers SE Kitts, CC Taylor-Edwards, DB Edwards, JB Cannon, AF Beckemeyer, ... JOURNAL OF DAIRY SCIENCE 90, 547-547, 2007 | 1 | 2007 |
